
|Articles|February 1, 2005
Wiping out Akt3 protein can stall tumor development
National report — The Akt3 protein seems responsible for promoting tumor cell survival and development in 43 percent to 60 percent of noninherited melanomas. And wiping out the protein in melanoma cells could stall tumor development and increase the chemo-sensitivity of this traditionally chemo-resistant cancer, according to a new study.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Transformative Advances This Year and Beyond
2
FDA Proposes Expansion of US Sunscreen Ingredient Standards with Bemotrizinol
3
Phase 3b Study Confirms Ligelizumab’s Consistent CSU Control
4
The SkinCARE Questionnaire: Assessing the Psychological Dimensions of Skin Health Beyond Disease
5


















